Basic Information
RETROVIR ORAL SOLUTION 10 mg/ml
SYRUP
Regulatory Information
SIN07527P
October 26, 1993
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
Company Information
Active Ingredients
Strength: 10 mg/ml
Detailed Information
Contraindications
**Contraindications** _RETROVIR_ is contraindicated in patients known to be hypersensitive to zidovudine, or to any of the components of the formulations. _RETROVIR_ should not be given to patients with abnormally low neutrophil counts (less than 0.75 x 109/l) or abnormally low haemoglobin levels (less than 7.5 g/dl or 4.65 mmol/l) ( _see Warnings and Precautions_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
Indication Information
**Indications** _RETROVIR_ is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and children.